BioSpace News Archive

Adolescent Sports Metrics (ASM) is offering free in-office UIL Pre-Participation Physicals for IRB (research) for all student athletes planning to participate in a school sponsored sport activity during the 2019-2020 school year.

Olympus Offers Solution to Prevent Endoscope Damage and the Associated Risk of Infection and Burden of Repair

Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announces positive Phase I safety and tolerability results of subcutaneous Acarovac MPL (Monophosphoryl Lipid A) in patients with house dust mite (HDM)-induced allergic rhinoconjunctivitis.

Investor conference call and webcast scheduled for Monday, June 17 at 8 a.m. EDT

Phase 2 Clinical Trial Enrollment Progresses While World Health Organization Provides Generic Name of AG013 Compound

Camber Spine, a leading innovator in spine and medical technologies, reported preliminary unaudited proprietary sales results for the first quarter ending March 31, 2019.

The Breakthrough Discovery Using Breast Milk Will Complete in 2019

A new analysis of financial data from general acute care hospitals in California reveals that private insurers paid on average 209 percent more than what Medicare paid for similar services in 2015 and 2016.

Reneo Pharmaceuticals announced that it has completed a $50 million Series A financing to develop therapies for diseases associated with deficits in cellular metabolism and energy production.

Neurocrine Biosciences, Inc. announced new data from RE-KINECT, the largest real-world screening study to date of patients with clinician-confirmed possible tardive dyskinesia, demonstrating the effect of involuntary movements on patient health-related quality of life.